Explore the intricate landscape of benzodiazepine treatment for anxiety disorders, providing clinicians with essential insights to optimize patient care. Participants will evaluate the nuanced risk-benefit profile of benzodiazepines as a first-line therapy, considering effectiveness, side effects, and long-term outcomes. Additionally, attendees will explore the diverse spectrum of treatment options for anxiety, including cognitive-behavioral therapy, motivational interviewing, shared decision-making, and psychoeducation, comparing their roles to benzodiazepine use. By the end of the session, clinicians will be equipped to develop comprehensive deprescribing strategies, identifying appropriate discontinuation scenarios, engaging in shared decision-making processes with patients, and seamlessly integrating alternative therapeutic modalities like CBT and MI into their treatment plans.